Alzheimer’s-related endosome dysfunction in Down syndrome is Aβ-independent but requires APP and is reversed by BACE-1 inhibition
暂无分享,去创建一个
Kerry A. Mullaney | S. Schmidt | P. Mathews | S. Ginsberg | R. Nixon | Shaoli Che | Ying Jiang | A. Cataldo | C. Peterhoff | Anne Boyer-Boiteau | Kerry Mullaney
[1] Christopher Lawrence,et al. DEGENERATION , 2020, Side Effects May Include Strangers.
[2] P. Mathews,et al. Age‐dependent dysregulation of brain amyloid precursor protein in the Ts65Dn Down syndrome mouse model , 2009, Journal of neurochemistry.
[3] R. Neve,et al. Down syndrome fibroblast model of Alzheimer-related endosome pathology: accelerated endocytosis promotes late endocytic defects. , 2008, The American journal of pathology.
[4] J. Schulz,et al. Efficient Inhibition of the Alzheimer's Disease β-Secretase by Membrane Targeting , 2008, Science.
[5] Ralph A. Nixon,et al. Autophagy, amyloidogenesis and Alzheimer disease , 2007, Journal of Cell Science.
[6] C. Kawas,et al. Alpha- and beta-secretase activity as a function of age and beta-amyloid in Down syndrome and normal brain , 2007, Neurobiology of Aging.
[7] K. Sleegers,et al. APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy. , 2006, Brain : a journal of neurology.
[8] Ahmad Salehi,et al. Increased App Expression in a Mouse Model of Down's Syndrome Disrupts NGF Transport and Causes Cholinergic Neuron Degeneration , 2006, Neuron.
[9] J. Wuu,et al. Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease , 2006, Journal of neurochemistry.
[10] C. Haass,et al. Amyloid Precursor Protein and Notch Intracellular Domains are Generated after Transport of their Precursors to the Cell Surface , 2006, Traffic.
[11] D. Campion,et al. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy , 2006, Nature Genetics.
[12] Inder M Verma,et al. Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model , 2005, Nature Neuroscience.
[13] M. Arbel,et al. Inhibition of amyloid precursor protein processing by beta-secretase through site-directed antibodies. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[14] R. Nixon. Endosome function and dysfunction in Alzheimer's disease and other neurodegenerative diseases , 2005, Neurobiology of Aging.
[15] C. Morris,et al. Influence of the amyloid precursor protein locus on dementia in Down syndrome , 2004, Neurology.
[16] T. Bird,et al. Intracellular accumulation of amyloidogenic fragments of amyloid-beta precursor protein in neurons with Niemann-Pick type C defects is associated with endosomal abnormalities. , 2004, The American journal of pathology.
[17] R. Nixon. Niemann-Pick Type C disease and Alzheimer's disease: the APP-endosome connection fattens up. , 2004, The American journal of pathology.
[18] L. Tsai,et al. BACE1 Suppression by RNA Interference in Primary Cortical Neurons* , 2004, Journal of Biological Chemistry.
[19] C. Epstein,et al. App Gene Dosage Modulates Endosomal Abnormalities of Alzheimer's Disease in a Segmental Trisomy 16 Mouse Model of Down Syndrome , 2003, The Journal of Neuroscience.
[20] B. Tycko,et al. Polymorphisms in the promoter of the human APP gene: functional evaluation and allele frequencies in Alzheimer disease. , 2002, Archives of neurology.
[21] M. Mercken,et al. Calpain Activity Regulates the Cell Surface Distribution of Amyloid Precursor Protein , 2002, The Journal of Biological Chemistry.
[22] M. Wolfe,et al. Continuing strategies for inhibiting alzheimer’s γ-secretase , 2002, Journal of Molecular Neuroscience.
[23] J. Hardy,et al. The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .
[24] R. Bernards,et al. A System for Stable Expression of Short Interfering RNAs in Mammalian Cells , 2002, Science.
[25] J. Rohrer,et al. Alzheimer's Disease-related Overexpression of the Cation-dependent Mannose 6-Phosphate Receptor Increases Aβ Secretion , 2002, The Journal of Biological Chemistry.
[26] J. Rohrer,et al. Alzheimer's disease-related overexpression of the cation-dependent mannose 6-phosphate receptor increases Abeta secretion: role for altered lysosomal hydrolase distribution in beta-amyloidogenesis. , 2002, The Journal of biological chemistry.
[27] M. Wolfe,et al. Continuing strategies for inhibiting Alzheimer's gamma-secretase. , 2002, Journal of molecular neuroscience : MN.
[28] Y. Suh,et al. Carboxyl‐terminal fragment of Alzheimer's APP destabilizes calcium homeostasis and renders neuronal cells vulnerable to excitotoxicity , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[29] B T Hyman,et al. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. , 2000, The American journal of pathology.
[30] J. Treanor,et al. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. , 1999, Science.
[31] H. Potter,et al. Chromosome Missegregation and Trisomy 21 Mosaicism in Alzheimer's Disease , 1999, Neurobiology of Disease.
[32] D. Holtzman,et al. Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[33] D. Selkoe,et al. Generation of amyloid β protein from its precursor is sequence specific , 1995, Neuron.
[34] D. Selkoe,et al. Generation of amyloid beta protein from its precursor is sequence specific. , 1995, Neuron.
[35] D. Selkoe,et al. Amyloid β-peptide is produced by cultured cells during normal metabolism , 1992, Nature.
[36] S. Sisodia. Beta-amyloid precursor protein cleavage by a membrane-bound protease. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[37] D. Selkoe,et al. Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. , 1992, Science.
[38] D. Teplow,et al. Amyloid beta-peptide is produced by cultured cells during normal metabolism. , 1992, Nature.